Ceftazidime activity in experimental pseudomonas pyelonephritis in rats

Area of Science:

• Nephrology
• Infectious Diseases
• Pharmacology

Background:

• Pyelonephritis is a serious kidney infection often caused by Gram-negative bacteria.
• Pseudomonas aeruginosa is a common opportunistic pathogen that can cause severe urinary tract infections.
• Effective antibiotic treatment is crucial for managing pyelonephritis and preventing complications.

Purpose of the Study:

• To evaluate the efficacy of ceftazidime in treating experimental unilateral pyelonephritis.
• To determine the impact of ceftazidime on bacterial load in infected and non-infected kidneys, as well as bladder urine.

Main Methods:

• Albino rats were induced with unilateral pyelonephritis using Pseudomonas aeruginosa.
• Intramuscular administration of ceftazidime at 25 mg/kg or 50 mg/kg, three times daily for 3 days.
• Bacterial counts were assessed in kidney tissue and bladder urine.

Main Results:

• Ceftazidime treatment significantly reduced Pseudomonas aeruginosa bacterial counts.
• Reduction in bacterial load was observed in both the experimentally infected (damaged) kidney and the contralateral (undamaged) kidney.
• Bacterial counts in bladder urine were also decreased following ceftazidime administration.

Conclusions:

• Ceftazidime demonstrates significant antimicrobial activity against Pseudomonas aeruginosa in a rat model of pyelonephritis.
• The antibiotic effectively penetrates renal tissue and reduces bacterial burden in both kidneys and urine.
• Ceftazidime is a potential therapeutic option for treating Pseudomonas aeruginosa-induced pyelonephritis.